<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We measured the coagulation and fibrinolytic parameters in patients with various <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">angiopathies</z:e> to clarify the usefulness of the parameters for the evaluation of vascular involvement </plain></SENT>
<SENT sid="1" pm="."><plain>The study included 65 patients with <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo> at the <z:hpo ids='HP_0011010'>chronic</z:hpo> stage, 47 diabetics with <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> associated with <z:e sem="disease" ids="C0025945" disease_type="Disease or Syndrome" abbrv="">diabetic microangiopathy</z:e>, 15 diabetics without <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e>, and 16 patients with vasculitic <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> associated with <z:e sem="disease" ids="C0748408,C0009326" disease_type="Disease or Syndrome" abbrv="">collagen diseases</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Control subjects were 45 patients with other <z:e sem="disease" ids="C1112108" disease_type="Disease or Syndrome" abbrv="">neurological disorders</z:e> without symptomatic <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">angiopathies</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo> at the <z:hpo ids='HP_0011010'>chronic</z:hpo> stage, the coagulation factor VIII (FVIII), <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand</z:e> factor (vWF), and platelet factor IV were elevated significantly as compared with age-matched controls </plain></SENT>
<SENT sid="4" pm="."><plain>Diabetics with <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> showed significantly elevated FVIII and vWF in comparison with diabetics without <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> and controls </plain></SENT>
<SENT sid="5" pm="."><plain>No significant difference in parameters concerning <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism was observed between the two groups of diabetics </plain></SENT>
<SENT sid="6" pm="."><plain>These findings suggest that elevated activities of the coagulation parameters reflect not merely the abnormalities in <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism but also the presence of <z:e sem="disease" ids="C0155765" disease_type="Disease or Syndrome" abbrv="">microangiopathy</z:e> which causes <z:e sem="disease" ids="C0011882" disease_type="Disease or Syndrome" abbrv="">diabetic neuropathy</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The patients with vasculitic <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> exhibited significantly elevated FVIII, vWF and fibrin/fibrinogen degradation products (FDP) </plain></SENT>
<SENT sid="8" pm="."><plain>The present study demonstrated that FVIII and vWF are useful parameters for the evaluation of the extent of vascular involvement in <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">angiopathies</z:e> of different etiologies </plain></SENT>
<SENT sid="9" pm="."><plain>It is important for the treatment of patients with the <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">angiopathies</z:e>, to monitor the coagulation parameters which reflect vascular involvement in addition to parameters for the disease activity </plain></SENT>
</text></document>